Have a personal or library account? Click to login
Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision Cover

Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision

Radiology and Oncology
Volume 54 (2020): Issue 3 (September 2020)
By: Martina Rebersek  
Open Access
|May 2020

Authors

Martina Rebersek

mrebersek@onko-i.si

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/raon-2020-0031 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 272 - 277
Submitted on: Mar 13, 2020
|
Accepted on: Apr 29, 2020
|
Published on: May 28, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
metastatic colorectal cancer,
heterogeneity,
biomarkers,
consensus molecular subtypes,
CMS1,
CMS2,
CMS3,
CMS4
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2020 Martina Rebersek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 54 (2020): Issue 3 (September 2020)Next article